EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Machine Learning–Based Survival Prediction Tool for Adrenocortical Carcinoma

Emre Sedar Saygili, Yasir S Elhassan, Alessandro Prete iD, Juliane Lippert, Barbara Altieri iD, Cristina L Ronchi iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Emre Sedar Saygili und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale 17020, T…. Hauptthemen laut MEDLINE: Machine Learning, Adrenocortical Carcinoma, Adrenal Cortex Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU COST Action CA20122, The Society of Endocrinology and Metabolism of Türkiye.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy with difficult to predict clinical outcomes. The S-GRAS score combines clinical and histopathological variables (tumor stage, grade, resection status, age, and symptoms) and showed good prognostic performance for patients with ACC.

Objective

To improve ACC prognostic classification by applying robust machine learning (ML) models.

Method

We developed ML models to enhance outcome prediction using the published S-GRAS dataset (n = 942) as the training cohort and an independent dataset (n = 152) for validation. Sixteen ML models were constructed based on individual clinical variables. The best-performing models were used to develop a web-based tool for individualized risk prediction.

Results

Quadratic Discriminant Analysis, Light Gradient Boosting Machine, and AdaBoost Classifier models exhibited the highest performance, predicting 5-year overall mortality (OM), and 1-year and 3-year disease progression (DP) with F1 scores of 0.79, 0.63, and 0.83 in the training cohort, and 0.72, 0.60, and 0.83 in the validation cohort. Sensitivity and specificity for 5-year OM were at 77% and 77% in the training cohort, and 65% and 81% in the validation cohort, respectively. A web-based tool (https://acc-survival.streamlit.app) was developed for easily applicable and individualized risk prediction of mortality and disease progression.

Conclusion

S-GRAS parameters can efficiently predict outcome in patients with ACC, even using a robust ML model approach. Our web app instantly estimates the mortality and disease progression for patients with ACC, representing an accessible tool to drive personalized management decisions in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningAdrenocortical CarcinomaAdrenal Cortex NeoplasmsHumansFemaleMalePrognosisMiddle AgedAdultAgedRisk AssessmentDisease Progression

Stichwörter der Autor:innen

adrenal cancermodelmortalityprecision medicineprognosis

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale 17020, Turkey.
  • Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK.
  • Department of Endocrinology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.
  • Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham B15 2TT, UK.
  • NIHR Birmingham Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK.
  • Institute of Human Genetics, University of Wuerzburg, 97070 Wuerzburg, Germany.

ORCID-Profile: Alessandro Prete, Barbara Altieri, Cristina L Ronchi

Förderung

  • EU COST Action CA20122
  • The Society of Endocrinology and Metabolism of Türkiye

Zitieren

APA

Saygili, E. S., Elhassan, Y. S., Prete, A., Lippert, J., Altieri, B., & Ronchi, C. L. (2025). Machine Learning–Based Survival Prediction Tool for Adrenocortical Carcinoma. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf096

Vancouver

Saygili ES, Elhassan YS, Prete A, Lippert J, Altieri B, Ronchi CL. Machine Learning–Based Survival Prediction Tool for Adrenocortical Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf096

BibTeX
@article{Saygili2025,
  author = {Saygili, Emre Sedar and Elhassan, Yasir S and Prete, Alessandro and Lippert, Juliane and Altieri, Barbara and Ronchi, Cristina L},
  title = {Machine Learning–Based Survival Prediction Tool for Adrenocortical Carcinoma},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf096}
}
Kostenlos starten →